These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28417953)

  • 21. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
    Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
    Elife; 2021 May; 10():. PubMed ID: 34002696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate, and cocaine responsiveness.
    Rao A; Sorkin A; Zahniser NR
    Synapse; 2013 Oct; 67(10):668-77. PubMed ID: 23564231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced dopamine transporter function in striatum during nicotine withdrawal.
    Hadjiconstantinou M; Duchemin AM; Zhang H; Neff NH
    Synapse; 2011 Feb; 65(2):91-8. PubMed ID: 20506223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
    Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
    Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system.
    Adinolfi A; Zelli S; Leo D; Carbone C; Mus L; Illiano P; Alleva E; Gainetdinov RR; Adriani W
    Behav Brain Res; 2019 Feb; 359():516-527. PubMed ID: 30472113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine.
    Delaney J; Nathani S; Tan V; Chavez C; Orr A; Paek J; Faraji M; Setlow B; Urs NM
    Neuropsychopharmacology; 2024 Sep; 49(10):1600-1608. PubMed ID: 38698264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine.
    Mingazov ER; Khakimova GR; Kozina EA; Medvedev AE; Buneeva OA; Bazyan AS; Ugrumov MV
    Mol Neurobiol; 2018 Apr; 55(4):2991-3006. PubMed ID: 28456940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered striatal dopamine levels in Parkinson's disease VPS35 D620N mutant transgenic aged mice.
    Vanan S; Zeng X; Chia SY; Varnäs K; Jiang M; Zhang K; Saw WT; Padmanabhan P; Yu WP; Zhou ZD; Halldin C; Gulyás B; Tan EK; Zeng L
    Mol Brain; 2020 Dec; 13(1):164. PubMed ID: 33261640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion.
    McGrath J; Lintz E; Hoffer BJ; Gerhardt GA; Quintero EM; Granholm AC
    Cell Transplant; 2002; 11(3):215-27. PubMed ID: 12075987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
    Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease.
    Bellucci A; Navarria L; Falarti E; Zaltieri M; Bono F; Collo G; Spillantini MG; Missale C; Spano P
    PLoS One; 2011; 6(12):e27959. PubMed ID: 22163275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
    Salvatore MF; Gerhardt GA; Dayton RD; Klein RL; Stanford JA
    Exp Neurol; 2009 Sep; 219(1):197-207. PubMed ID: 19460370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
    J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.
    Wu N; Cepeda C; Zhuang X; Levine MS
    J Neurophysiol; 2007 Jul; 98(1):423-32. PubMed ID: 17522168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience.
    Savchenko A; Targa G; Fesenko Z; Leo D; Gainetdinov RR; Sukhanov I
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems.
    Ji J; Bourque M; Di Paolo T; Dluzen DE
    Biochem Pharmacol; 2009 Dec; 78(11):1401-11. PubMed ID: 19615345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.
    O'Neill B; Tilley MR; Han DD; Thirtamara-Rajamani K; Hill ER; Bishop GA; Zhou FM; During MJ; Gu HH
    Neuropharmacology; 2014 Apr; 79():626-33. PubMed ID: 24412674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.